首页> 美国卫生研究院文献>Vaccines >Edwardsiella tarda OmpA Encapsulated in Chitosan Nanoparticles Shows Superior Protection over Inactivated Whole Cell Vaccine in Orally Vaccinated Fringed-Lipped Peninsula Carp (Labeo fimbriatus)
【2h】

Edwardsiella tarda OmpA Encapsulated in Chitosan Nanoparticles Shows Superior Protection over Inactivated Whole Cell Vaccine in Orally Vaccinated Fringed-Lipped Peninsula Carp (Labeo fimbriatus)

机译:封装在壳聚糖纳米颗粒中的爱德华氏菌OmpA显示出比灭活的全口唇唇猴(Labeo fimbriatus)灭活的全细胞疫苗更好的保护。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The use of oral vaccination in finfish has lagged behind injectable vaccines for a long time as oral vaccines fall short of injection vaccines in conferring protective immunity. Biodegradable polymeric nanoparticles (NPs) have shown potential to serve as antigen delivery systems for oral vaccines. In this study the recombinant outer membrane protein A (rOmpA) of Edwardsiella tarda was encapsulated in chitosan NPs (NP-rOmpA) and used for oral vaccination of Labeo fimbriatus. The rOmpA purity was 85%, nanodiameter <500 nm, encapsulation efficiency 60.6%, zeta potential +19.05 mV, and there was an in vitro release of 49% of encapsulated antigen within 48 h post incubation in phosphate-buffered saline. Empty NPs and a non-formulated, inactivated whole cell E. tarda (IWC-ET) vaccine were used as controls. Post-vaccination antibody levels were significantly (p = 0.0458) higher in the NP-rOmpA vaccinated fish (Mean OD450 = 2.430) than in fish vaccinated with inactivated whole cell E. tarda (IWC-ET) vaccine (Mean OD450 = 1.735), which corresponded with post-challenge survival proportions (PCSP) of 73.3% and 48.28% for the NP-rOmpA and IWC-ET groups, respectively. Serum samples from NP-rOmpA-vaccinated fish had a higher inhibition rate for E. tarda growth on tryptic soy agar (TSA) than the IWC-ET group. There was no significant difference (p = 0.989) in PCSPs between fish vaccinated with empty NPs and the unvaccinated control fish, while serum from both groups showed no detectable antibodies against E. tarda. Overall, these data show that the NP-rOmpA vaccine produced higher antibody levels and had superior protection over the IWC-ET vaccine, showing that encapsulating OmpA in chitosan NPs confer improved protection against E. tarda mortality in L. fimbriatus. There is a need to elucidate the possible adjuvant effects of chitosan NPs and the immunological mechanisms of protective immunity induced by OMPs administered orally to fish.
机译:在有鳍鱼中口服疫苗的使用已经落后于注射疫苗很长时间了,因为口服疫苗在提供保护性免疫方面不及注射疫苗。可生物降解的聚合物纳米颗粒(NPs)已显示出潜力,可作为口服疫苗的抗原传递系统。在这项研究中,将爱德华氏菌的重组外膜蛋白A(rOmpA)封装在壳聚糖NP(NP-rOmpA)中,并用于唇形唇菌的口服疫苗接种。 rOmpA纯度为85%,纳米直径<500 nm,包封效率60.6%,ζ电位+19.05 mV,在磷酸盐缓冲液中孵育48小时后,体外释放了49%的包埋抗原。空的NP和未配制的灭活的全细胞焦油大肠埃希氏菌(IWC-ET)疫苗用作对照。在NP-rOmpA疫苗接种的鱼中(平均OD450 = 2.430),接种疫苗后的抗体水平显着(p = 0.0458),而在接种灭活的全细胞塔氏大肠杆菌(IWC-ET)疫苗的鱼中(平均OD450 = 1.735), NP-rOmpA和IWC-ET组的攻击后生存率(PCSP)分别为73.3%和48.28%。 NP-rOmpA疫苗接种鱼的血清样品对胰蛋白酶大豆琼脂(TSA)的塔氏大肠杆菌生长的抑制率高于IWC-ET组。接种空NP的鱼与未接种的对照鱼之间的PCSP差异无统计学意义(p = 0.989),而两组的血清均未检测到抗焦油大肠埃希菌的抗体。总体而言,这些数据表明,NP-rOmpA疫苗产生的抗体水平更高,并且具有比IWC-ET疫苗更高的保护作用,表明将OmpA封装在壳聚糖NP中可以提高抵抗纤毛乳杆菌中塔氏大肠杆菌死亡的保护作用。有必要阐明壳聚糖NP的可能的佐剂作用以及口服给予鱼类的OMP诱导的保护性免疫的免疫机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号